The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Ginkgo Bioworks Holdings Inc’s current trading price is -87.45% away from its 52-week high, while its distance from the 52-week low is 79.47%. The stock’s price range for this period has been between $5.26 and $75.20 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.5 million for the day, a number notably higher than the average daily volume of 1.29 million over the last three months.
Ginkgo Bioworks Holdings Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $75.20 on 12/20/23, while the lowest value for the same period was recorded at $5.26 on 09/10/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly rise of 51.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 495.85M and boasts a workforce of 1218 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.69, with a change in price of -2.68. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,373,170 in trading volume during the last 100 days, posting a change of -22.11%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.56. Similarly, the long-term debt-to-equity ratio is also 0.56.
DNA Stock Stochastic Average
As of today, Ginkgo Bioworks Holdings Inc’s raw stochastic average for the last 50 days stands at 57.45%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 57.45%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 69.46% and 76.07%, respectively.
DNA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -86.04% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -47.52%. Over the past 30 days, the price of DNA has fallen by 9.77%. And in the last five days, it has fallen by -19.04%.
